Preliminary Evaluation for the Development of a Scoring System to Predict Homozygous M694V Genotype in Familial Mediterranean Fever Patients
- 1 January 2025
- journal article
- research article
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 31 (1) , 7-11
Abstract
Objective: The aim of this study was to identify key parameters of a scoring system to be developed to predict the homozygous M694V genotype in patients clinically diagnosed with familial Mediterranean fever. Methods: This study was a cross-sectional analysis of 472 pediatric familial Mediterranean fever patients with a homozygous genotype on exon 10, followed at our tertiary pediatric rheumatology clinic between June 2016 and June 2023. The patients were categorized into 2 groups based on their genotypes: group 1 comprised 402 patients (85.2%) with the homozygous M694V genotype, whereas group 2 consisted of 70 patients (14.8%) with other homozygous genotypes. Demographic information, clinical manifestations, MEFV (Mediterranean fever) gene variant analysis, and treatment responses were recorded from the patients' medical charts. Results: The odds ratios for age at disease onset, arthritis, and chest pain were 0.892 (95% confidence interval [CI]: 0.832–0.958, p = 0.002), 2.565 (95% CI: 1.109–5.934, p = 0.028), and 2.351 (95% CI: 1.123–4.922, p = 0.023), respectively. A total of 60.7% of patients in group 1 had arthralgia, and 25% had erysipelas-like erythema, with these percentages were higher in group 1 compared with group 2 (p = 0.002, p = 0.001, respectively). Protracted febrile myalgia syndrome was detected in 1.5% of patients, all of whom had homozygous M694V genotype. Colchicine resistance was detected in 13.3% of patients, and all had homozygous M694V genotype. Conclusions: This preliminary evaluation identified key parameters for a scoring system designed to predict the homozygous M694V genotype. A multicenter national study will further refine these parameters and develop the scoring system, which will aid clinicians in disease prognosis and therapeutic decision-making.Keywords
This publication has 32 references indexed in Scilit:
- Genotype–phenotype associations in familial Mediterranean fever: a study of 500 Egyptian pediatric patientsClinical Rheumatology, 2022
- Comorbidities and phenotype–genotype correlation in children with familial Mediterranean feverRheumatology International, 2020
- A comprehensive molecular analysis and genotype–phenotype correlation in patients with familial mediterranean feverMolecular Biology Reports, 2020
- Familial Mediterranean fever in childhood: a single-center experienceRheumatology International, 2017
- The myths we believed in familial Mediterranean fever: what have we learned in the past years?Seminars in Immunopathology, 2015
- The MEFV mutations and their clinical correlations in children with familial Mediterranean fever in southeast TurkeyRheumatology International, 2013
- Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, TurkeyClinical Rheumatology, 2011
- Familial Mediterranean fever gene mutation frequencies and genotype–phenotype correlations in the Aegean region of TurkeyRheumatology International, 2010
- Decrease in the rate of secondary amyloidosis in Turkish children with FMF: are we doing better?European Journal of Pediatrics, 2010
- A High-Resolution Genetic Map of the Familial Mediterranean Fever Candidate Region Allows Identification of Haplotype-Sharing among Ethnic GroupsGenomics, 1997